Evaluating New Therapies in HF

Hospitalizations and Healthcare Costs: Need for Reduction in Hospitalizations of HF Patients

From HF-Centric Thinking to Patient-Centered Thinking

EMPA-REG OUTCOME®: Important Features

SPRINT Research Question

Prevention Is Challenging to Treat

Even Common Therapies Are Underdosed

Two New HF Therapies Approved

Uptitrate 1 Drug at a Time

When to Consider Ivabradine

Ivabradine (cont)

PARADIGM-HF

Failure to Prescribe Newer Agents

Cost/Benefit of New Therapy

Be Proactive and Reduce Physician Inertia

A Multifactorial Approach Is Needed: GWTG-HF Medication Initiation Burden

Summary

Abbreviations

Abbreviations (cont)